from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3630/-

LFCtreatmentdescriptionclass of inhibitor

-0.682

Amikacinug/mL Amikacintranslation

-0.440

Cap5-10ug/mL Capreomycintranslation

-0.099

Rox10-50 ug/mL Roxithromycintranslation

-0.362

SM2-5 ug/mL Streptomycintranslation

-1.057

Tet5-10 ug/mL Tetracyclinetranslation

1.500

Rif0.2-5ug/mL Rifampicintranscription

-1.223

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.634

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.291

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.748

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.494

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.267

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.668

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.519

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.950

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.100

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.217

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.520

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.431

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.707

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.368

KCN5-20 ug/mL Potassium cyaniderespiration

1.264

NaN30.2-2 mM Sodium aziderespiration

-1.039

Nigericin50 uM Nigericinrespiration

-0.417

TRC10-150 ug/mL Triclosanrespiration

-1.706

TRZ10-25 ug/mL Thioridazinerespiration

-2.024

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.021

menadione6-10 ug/mL Menadionerespiration

-0.510

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.415

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.858

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.494

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.230

NRP_1Non-replicating persistence stage 1dosRassociated

0.213

Amp0.2mg/mL AmpicillincellWall

0.369

Cephalexin20-100 ug/mL CephalexincellWall

0.286

Cerulenin0.32-5 ug/mL CerulenincellWall

0.426

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.133

EMB10-20 ug/mL EthambutolcellWall

0.162

Eta12-40 ug/mL EthionamidecellWall

0.612

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.448

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.388

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.077

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.042

BZA0.12 mg/mL BenzamidearomaticAmides

0.860

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.808

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.037

H2O24 mM hydrogen peroxideDNAdamaging

0.078

Levo10 ug/mL LevofloxacinDNAdamaging

0.692

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.196

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.739

UVUV-irradiationDNAdamaging

-0.315

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.254

Antimycin12.5-50 ug/mL Antimycin A?

-0.785

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.513

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.592

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.237

PA8240.2-2 ug/mL PA-824?

-0.179

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.460

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.242

Verapamil50 uM Verapamil?

-0.947

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.511

methoxatin10-20 ug/mL Methoxatin?